Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Mouse SEMA3B ELISA Kit (AC2660)
Cat.#: ASET-1249
Specifications
Description Mouse SEMA3B ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of mouse SEMA3B concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.058 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 1.5-24 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2289 Rat Dehydroepiandrosterone ELISA Kit (AC3700) Quantitative inquiry ASET-2208 Human Homer1 ELISA Kit (AC3619) Quantitative inquiry ASET-1031 Mouse Prealbumin ELISA Kit (AC2442) Quantitative inquiry ASET-2528 Human Neuropeptide S ELISA Kit (AC3939) Quantitative inquiry ASET-1373 Human Laminin 2 alpha ELISA Kit (AC2784) Quantitative inquiry ASET-1002 Human HDL ELISA Kit (AC2413) Quantitative inquiry ASET-1129 Rat CNTF ELISA Kit (AC2540) Quantitative inquiry ASET-2309 Human NECL-1 ELISA Kit (AC3720) Quantitative inquiry ASET-1843 Human CRCP ELISA Kit (AC3254) Quantitative inquiry ASET-1972 Human Progranulin ELISA Kit (AC3383) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket